0078-0539 : Tyzeka 20 mg/ml Oral Solution


NDC: 0078-0539
Labeler: Novartis Pharmaceuticals Corporation
Product Type: Human Prescription Drug
Drug Name:  Tyzeka
Dosage Form: Oral Solution
Application #: NDA022154
Rev. Date: 


NDC Package Codes:

  • 0078-0539-85: 300 ML IN 1 BOTTLE (0078‑0539‑85)

Active Ingredients:

  • Telbivudine

Dosage Strength:

  • 20 mg/mL

Pharmaceutical Classes:

  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Analog [Chemical/Ingredient]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0078-0538 Tyzeka 600 mg Oral Tablet by Novartis Pharmaceuticals Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0078-0539 QR Code

< Prev: 0078-0538Next: 0078-0544 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.